Report cover image

Stem Cell Assays Market Size, Share & Trends Analysis Report By Product (Instruments, Kits & Reagents), By Assay Type (Cell Viability Assay, Differentiation Assay, Proliferation Assay, Apoptosis Assay), By Cell Type, By Application, By End-use, By Region,

Publisher Grand View Research
Published Oct 08, 2025
Length 150 Pages
SKU # GV20575015

Description

Stem Cell Assays Market Summary

The global stem cell assays market size was estimated at USD 3.92 billion in 2024 and is projected to reach USD 12.85 billion by 2033, growing at a CAGR of 14.80% from 2025 to 2033. The growing need for physiologically relevant models in drug discovery, disease modeling, and regenerative medicine is the main factor propelling the market growth.

Pharmacies and researchers are looking for trustworthy platforms resembling human tissues more closely than conventional models, like organoid and iPSC-based systems. By improving drug efficacy and safety prediction, these assays lower late-stage failure rates and speed up the creation of novel treatments.

Global Stem Cell Assays Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global stem cell assays market report based on product, assay type, cell type, application, end-use, and region:
  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Instruments
  • Kits & Reagents
  • Assay Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Cell Viability Assay
  • Differentiation Assay
  • Proliferation Assay
  • Apoptosis Assay
  • Others
  • Cell Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Adult stem cells
  • embryonic stem cells
  • induced pluripotent stem cells
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Regenerative Medicine & Therapy Development
  • Drug Discovery
  • Toxicity Testing
  • Clinical Research
  • Others
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Academic and Research Institutions
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
Please note The report will be delivered in 2-3 business days upon order notification.

Table of Contents

150 Pages
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Product Segment
1.2.2. Assay Type Segment
1.2.3. Cell Type Segment
1.2.4. Application Segment
1.2.5. End Use Segment
1.3. Information Analysis
1.3.1. Market formulation & data visualization
1.4. Data Validation & Publishing
1.5. Information Procurement
1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives
1.10.1. Objective 1
1.10.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
Chapter 3. Stem Cell Assays Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing funding for stem cell research
3.2.1.2. Growing demand for physiologically relevant models in drug discovery, regenerative medicine, and disease modeling
3.2.2. Market restraint analysis
3.2.2.1. Lack of stringent regulation
3.2.2.2. High costs of advanced stem cell assays and associated instruments.
3.3. Stem Cell Assays Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
Chapter 4. Stem Cell Assays Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Stem Cell Assays Market Product Movement Analysis
4.3. Global Stem Cell Assays Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
4.4. Instruments
4.4.1. Instruments market estimates and forecasts 2021 to 2033 (USD Million)
4.5. Kits & Reagents
4.5.1. Kits & Reagents market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 5. Stem Cell Assays Market: Assay Type Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Stem Cell Assays Market Assay Type Movement Analysis
5.3. Global Stem Cell Assays Market Size & Trend Analysis, by Assay Type, 2021 to 2033 (USD Million)
5.4. Cell Viability Assay
5.4.1. Cell viability assay market estimates and forecasts 2021 to 2033 (USD Million)
5.5. Differentiation Assay
5.5.1. Differentiation assay market estimates and forecasts 2021 to 2033 (USD Million)
5.6. Proliferation Assay
5.6.1. Proliferation assay market estimates and forecasts 2021 to 2033 (USD Million)
5.7. Apoptosis Assay
5.7.1. Apoptosis assay market estimates and forecasts 2021 to 2033 (USD Million)
5.8. Others
5.8.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 6. Stem Cell Assays Market: Cell Type Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global Stem Cell Assays Market Cell Type Movement Analysis
6.3. Global Stem Cell Assays Market Size & Trend Analysis, by Cell Type, 2021 to 2033 (USD Million)
6.4. Adult Stem Cells
6.4.1. Adult stem cells market estimates and forecasts 2021 to 2033 (USD Million)
6.5. Embryonic Stem Cells
6.5.1. Embryonic stem cells market estimates and forecasts 2021 to 2033 (USD Million)
6.6. Induced Pluripotent Stem Cells
6.6.1. Induced pluripotent stem cells market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 7. Stem Cell Assays Market: Application Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Global Stem Cell Assays Market Application Movement Analysis
7.3. Global Stem Cell Assays Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
7.4. Regenerative Medicine & Therapy Development
7.4.1. Regenerative medicine & therapy development market estimates and forecasts 2021 to 2033 (USD Million)
7.5. Drug discovery
7.5.1. Drug discovery market estimates and forecasts 2021 to 2033 (USD Million)
7.6. Toxicity testing
7.6.1. Toxicity testing market estimates and forecasts 2021 to 2033 (USD Million)
7.7. Clinical Research
7.7.1. Clinical research market estimates and forecasts 2021 to 2033 (USD Million)
7.8. Others
7.8.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 8. Stem Cell Assays Market: End Use Estimates & Trend Analysis
8.1. Segment Dashboard
8.2. Global Stem Cell Assays Market End Use Movement Analysis
8.3. Global Stem Cell Assays Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
8.4. Academic and Research Institutions
8.4.1. Academic and research institutions market estimates and forecasts 2021 to 2033 (USD Million)
8.5. Pharmaceutical and Biotechnology Companies
8.5.1. Pharmaceutical and biotechnology companies market estimates and forecasts 2021 to 2033 (USD Million)
8.6. Contract Research Organizations
8.6.1. Contract research organizations market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 9. Stem Cell Assays Market: Regional Estimates & Trend Analysis
9.1. Regional Market Share Analysis, 2024 & 2033
9.2. Regional Market Dashboard
9.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
9.4. North America
9.4.1. U.S.
9.4.1.1. Key country dynamics
9.4.1.2. Competitive scenario
9.4.1.3. Regulatory Framework
9.4.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
9.4.2. Canada
9.4.2.1. Key country dynamics
9.4.2.2. Competitive scenario
9.4.2.3. Regulatory Framework
9.4.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
9.4.3. Mexico
9.4.3.1. Key country dynamics
9.4.3.2. Competitive scenario
9.4.3.3. Regulatory Framework
9.4.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
9.5. Europe
9.5.1. UK
9.5.1.1. Key country dynamics
9.5.1.2. Competitive scenario
9.5.1.3. Regulatory Framework
9.5.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
9.5.2. Germany
9.5.2.1. Key country dynamics
9.5.2.2. Competitive scenario
9.5.2.3. Regulatory Framework
9.5.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
9.5.3. France
9.5.3.1. Key country dynamics
9.5.3.2. Competitive scenario
9.5.3.3. Regulatory Framework
9.5.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
9.5.4. Italy
9.5.4.1. Key country dynamics
9.5.4.2. Competitive scenario
9.5.4.3. Regulatory Framework
9.5.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
9.5.5. Spain
9.5.5.1. Key country dynamics
9.5.5.2. Competitive scenario
9.5.5.3. Regulatory Framework
9.5.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
9.5.6. Norway
9.5.6.1. Key country dynamics
9.5.6.2. Competitive scenario
9.5.6.3. Regulatory Framework
9.5.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
9.5.7. Sweden
9.5.7.1. Key country dynamics
9.5.7.2. Competitive scenario
9.5.7.3. Regulatory Framework
9.5.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
9.5.8. Denmark
9.5.8.1. Key country dynamics
9.5.8.2. Competitive scenario
9.5.8.3. Regulatory Framework
9.5.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
9.6. Asia Pacific
9.6.1. Japan
9.6.1.1. Key country dynamics
9.6.1.2. Competitive scenario
9.6.1.3. Regulatory Framework
9.6.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
9.6.2. China
9.6.2.1. Key country dynamics
9.6.2.2. Competitive scenario
9.6.2.3. Regulatory Framework
9.6.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
9.6.3. India
9.6.3.1. Key country dynamics
9.6.3.2. Competitive scenario
9.6.3.3. Regulatory Framework
9.6.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
9.6.4. Australia
9.6.4.1. Key country dynamics
9.6.4.2. Competitive scenario
9.6.4.3. Regulatory Framework
9.6.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
9.6.5. South Korea
9.6.5.1. Key country dynamics
9.6.5.2. Competitive scenario
9.6.5.3. Regulatory Framework
9.6.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
9.6.6. Thailand
9.6.6.1. Key country dynamics
9.6.6.2. Competitive scenario
9.6.6.3. Regulatory Framework
9.6.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
9.7. Latin America
9.7.1. Brazil
9.7.1.1. Key country dynamics
9.7.1.2. Competitive scenario
9.7.1.3. Regulatory Framework
9.7.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
9.7.2. Argentina
9.7.2.1. Key country dynamics
9.7.2.2. Competitive scenario
9.7.2.3. Regulatory Framework
9.7.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
9.8. MEA
9.8.1. South Africa
9.8.1.1. Key country dynamics
9.8.1.2. Competitive scenario
9.8.1.3. Regulatory Framework
9.8.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
9.8.2. Saudi Arabia
9.8.2.1. Key country dynamics
9.8.2.2. Competitive scenario
9.8.2.3. Regulatory Framework
9.8.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
9.8.3. UAE
9.8.3.1. Key country dynamics
9.8.3.2. Competitive scenario
9.8.3.3. Regulatory Framework
9.8.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
9.8.4. Kuwait
9.8.4.1. Key country dynamics
9.8.4.2. Competitive scenario
9.8.4.3. Regulatory Framework
9.8.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 10. Competitive Landscape
10.1. Company/Competition Categorization
10.2. Strategy Mapping
10.3. Company Market Position Analysis, 2024
10.4. Company Profiles/Listing
10.4.1. Thermo Fisher Scientific Inc.
10.4.1.1. Company overview
10.4.1.2. Financial performance
10.4.1.3. Product/Service benchmarking
10.4.1.4. Strategic initiatives
10.4.2. Merck KGaA
10.4.2.1. Company overview
10.4.2.2. Financial performance
10.4.2.3. Product/Service benchmarking
10.4.2.4. Strategic initiatives
10.4.3. STEMCELL Technologies Inc.
10.4.3.1. Company overview
10.4.3.2. Financial performance
10.4.3.3. Product/Service benchmarking
10.4.3.4. Strategic initiatives
10.4.4. Corning Incorporated
10.4.4.1. Company overview
10.4.4.2. Financial performance
10.4.4.3. Product/Service benchmarking
10.4.4.4. Strategic initiatives
10.4.5. Danaher Corporation
10.4.5.1. Company overview
10.4.5.2. Financial performance
10.4.5.3. Product/Service benchmarking
10.4.5.4. Strategic initiatives
10.4.6. Lonza
10.4.6.1. Company overview
10.4.6.2. Financial performance
10.4.6.3. Product/Service benchmarking
10.4.6.4. Strategic initiatives
10.4.7. Bio-Rad Laboratories, Inc.
10.4.7.1. Company overview
10.4.7.2. Financial performance
10.4.7.3. Product/Service benchmarking
10.4.7.4. Strategic initiatives
10.4.8. PerkinElmer, Inc.
10.4.8.1. Company overview
10.4.8.2. Financial performance
10.4.8.3. Product/Service benchmarking
10.4.8.4. Strategic initiatives
10.4.9. PromoCell GmbH
10.4.9.1. Company overview
10.4.9.2. Financial performance
10.4.9.3. Product/Service benchmarking
10.4.9.4. Strategic initiatives
10.4.10. Bio-Techne Corporation
10.4.10.1. Company overview
10.4.10.2. Financial performance
10.4.10.3. Product/Service benchmarking
10.4.10.4. Strategic initiatives

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us